Efficacy of platelet-rich plasma in treatment of androgenic alopecia

Efficacy of platelet-rich plasma in treatment of androgenic alopecia

Platelet-rich plasma (PRP) has shown remarkable beneficial effects without any major adverse reactions in the treatment of androgenic alopecia. The growth factors in activated autologous PRP induce the proliferation of dermal papilla cells. The objective was to investigate the clinical efficacy of P...

Full description

Saved in:
Bibliographic Details
Published in:Asian journal of transfusion science Vol. 9; no. 2; pp. 159 - 162
Main Authors: Singhal, Parul, Agarwal, Sachin, Dhot, Paramjeet Singh, Sayal, Satish K
Format: Journal Article
Language:English
Published: India Medknow Publications and Media Pvt. Ltd 01-07-2015
Medknow Publications & Media Pvt. Ltd
Medknow Publications & Media Pvt Ltd
Wolters Kluwer Medknow Publications
Subjects:
Age
Alopecia
Androgenic
Androgens
Baldness
Blood platelets
Care and treatment
Epidermal growth factor
Hair loss
Hemophilia
Insulin
Original
Patients
Plasma
platelet rich plasma
alopecia
Androgenic
platelet rich plasma
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Platelet-rich plasma (PRP) has shown remarkable beneficial effects without any major adverse reactions in the treatment of androgenic alopecia. The growth factors in activated autologous PRP induce the proliferation of dermal papilla cells. The objective was to investigate the clinical efficacy of PRP in treatment of androgenic alopecia. Ten patients were given autologous PRP injections on the affected area of alopecia over a period of 3 months at interval of 2-3 weeks and results were assessed. Three months after the treatment, the patients presented clinical improvement in the hair counts, hair thickness, hair root strength, and overall alopecia. PRP appears to be a cheap, effective, and promising therapy for androgenic alopecia with no major adverse effects.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0973-6247
1998-3565
DOI:10.4103/0973-6247.162713